United States · FDA National Drug Code directory
Glipizide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2353_bb8758a7-c9c3-4a5f-b96f-3cb8957535c9
- Product NDC
- 71335-2353
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Glipizide
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230303
- Source listing expiry
- 20271231
Source-listed ingredients
- GLIPIZIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-1) · 71335-2353-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-2) · 71335-2353-2
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-3) · 71335-2353-3
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-4) · 71335-2353-4
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2353-5) · 71335-2353-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →